{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:00:32Z","timestamp":1785074432558,"version":"3.55.0"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118161","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:29:53Z","timestamp":1781540993000},"page":"118161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Current progress in the use of pyrazole-containing compounds for neuroprotection as a strategy to counteract neurodegeneration"],"prefix":"10.1016","volume":"251","author":[{"given":"In\u00eas M.","family":"Bastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela R.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rebelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0938-5085","authenticated-orcid":false,"given":"Vera L.M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2026.118161_b0005","first-page":"499","article-title":"Neurodegenerative Disease: Models, Mechanisms, and a New Hope","volume":"10","author":"Gitler","year":"2017","journal-title":"Co., Biol."},{"issue":"51","key":"10.1016\/j.bcp.2026.118161_b0010","first-page":"1","article-title":"Fluorescent Diagnostic Probes in Neurodegenerative Diseases","volume":"32","author":"Zhou","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bcp.2026.118161_b0015","first-page":"301","article-title":"Concepts and Classification of Neurodegenerative Diseases","author":"Kovacs","year":"2018","journal-title":"Handbook of Clinical Neurology, Elsevier"},{"issue":"4","key":"10.1016\/j.bcp.2026.118161_b0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of Neurodegenerative Diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph11020044","article-title":"Old Drugs as New Treatments for Neurodegenerative Diseases","volume":"11","author":"Dur\u00e3es","year":"2018","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.bcp.2026.118161_b0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.52601\/bpr.2022.220013","article-title":"Brain Structure and Structural Basis of Neurodegenerative Diseases","volume":"8","author":"Yang","year":"2022","journal-title":"Biophys. Reports"},{"key":"10.1016\/j.bcp.2026.118161_b0035","first-page":"359","article-title":"Economic Importance of Medicinal Plants in Asian Countries. Bioeconomy for","author":"Zahra","year":"2020","journal-title":"Sustain. Dev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0040","first-page":"1","article-title":"Genealogy of the Neurodegenerative Diseases based on a Meta-Analysis of Age-Stratified Incidence Data","volume":"10","author":"Gerovska","year":"2020","journal-title":"Nat. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118161_b0045","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer's Disease Facts and Figures","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"20","key":"10.1016\/j.bcp.2026.118161_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27206804","article-title":"Alzheimer\u2019s Disease as a Major Public Health concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and their underlying Mechanisms","volume":"27","author":"Abduljawad","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.118161_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00221","article-title":"\u03b2-Amyloid: the Key Peptide in the Pathogenesis of Alzheimer\u2019s Disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2026.118161_b0060","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal Phosphorylation of the Microtubule-Associated Protein \u03c4 (Tau) in Alzheimer Cytoskeletal Pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118161_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2022.996030","article-title":"Biological and Disease Hallmarks of Alzheimer\u2019s Disease Defined by Alzheimer\u2019s Disease Genes","volume":"14","author":"Murakami","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/bioengineering11010045","article-title":"Alzheimer\u2019s Disease: Models and Molecular Mechanisms Informing Disease and Treatments","volume":"11","author":"Nystuen","year":"2024","journal-title":"Bioengineering"},{"key":"10.1016\/j.bcp.2026.118161_b0075","doi-asserted-by":"crossref","unstructured":"Bellozi, P. M. Q.; Gomes, G. F.; da Silva, M. C. M.; Lima, I. V. de A.; Batista, C. R. \u00c1.; Carneiro Junior, W. de O.; D\u00f3ria, J. G.; Vieira, \u00c9. L. M.; Vieira, R. P.; de Freitas, R. P.; Ferreira, C. N.; Candelario-Jalil, E.; Wyss-Coray, T.; Ribeiro, F. M.; de Oliveira, A. C. P. A Positive Allosteric Modulator of MGluR5 Promotes Neuroprotective Effects in Mouse Models of Alzheimer\u2019s Disease. Neuropharmacology 2019, 160, 1\u201317. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107785.","DOI":"10.1016\/j.neuropharm.2019.107785"},{"issue":"6","key":"10.1016\/j.bcp.2026.118161_b0080","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for Neurodegenerative Diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.118161_b0085","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","article-title":"Tau in the Pathophysiology of Parkinson\u2019s Disease","volume":"71","author":"Pan","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2026.118161_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2022.105940","article-title":"The complex Role of Inflammation and Gliotransmitters in Parkinson\u2019s Disease","volume":"176","author":"Gopinath","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2026.118161_b0095","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s12276-022-00895-w","article-title":"Inflammation Promotes Synucleinopathy Propagation","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2026.118161_b0100","first-page":"82","article-title":"Environmental Factors and the Emerging Role of Epigenetics in Neurodegenerative Diseases","volume":"667","author":"Migliore","year":"2009","journal-title":"Mutat. Res. - Fundam. Mol. Mech. Mutagen."},{"key":"10.1016\/j.bcp.2026.118161_b0105","first-page":"1","article-title":"Experimental and innovative Approaches to Multi-Target Treatment of Parkinson\u2019s and Alzheimer\u2019s Diseases- volume II","author":"Tikhonova","year":"2023","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.47583\/ijpsrr.2020.v65i01.030","article-title":"Chemistry and Pharmacological Activities of Pyrazole and Pyrazole Derivatives: a Review","volume":"65","author":"Singh","year":"2020","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.bcp.2026.118161_b0115","doi-asserted-by":"crossref","unstructured":"Eicher, T.; Hauptmann, S.; Speicher, A. The Chemistry of Heterocycles: Structure, Reactions, Syntheses, and Applications, 2nd ed.; Wiley-VCH, 2003. doi: 10.1002\/352760183X.","DOI":"10.1002\/352760183X"},{"key":"10.1016\/j.bcp.2026.118161_b0120","article-title":"Pyrazoles, Pyrazolines, Pyrazolidines, Indazoles and Condensed Rings","volume":"3\u201312","author":"Behr","year":"1967","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.bcp.2026.118161_b0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejmech.2018.07.007","article-title":"Current Progress on Antioxidants Incorporating the Pyrazole Core","volume":"156","author":"Silva","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.aihch.2017.06.003","article-title":"Tautomerism and Structure of Azoles: Nuclear magnetic Resonance Spectroscopy","volume":"124","author":"Katritzky","year":"2018","journal-title":"Adv. Heterocycl. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/molecules25010042","article-title":"Revisiting the Structure and Chemistry of 3(5)-Substituted Pyrazoles","volume":"25","author":"Secrieru","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.118161_b0140","first-page":"1","article-title":"Synthesis of Pyrazole and Pyrazoline Derivatives of \u03b2-Ionone: Exploring Anti-Inflammatory potential, Cytotoxicity, and Molecular Docking Insights","volume":"12","author":"Sihag","year":"2024","journal-title":"Eur. J. Med. Chem. Reports"},{"key":"10.1016\/j.bcp.2026.118161_b0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2013.08.053","article-title":"Pyrazole Containing Natural Products: Synthetic Preview and Biological significance","volume":"69","author":"Kumar","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118161_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4236\/cm.2013.43015","article-title":"Houttuynia Cordata Thunb\u00a0: a Review of Phytochemistry and Pharmacology and Quality Control","volume":"4","author":"Fu","year":"2013","journal-title":"Chin. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.jbchem.a126428","article-title":"Nonylpyrazole, a New Antimicrobial Substance","volume":"41","author":"Kosuge","year":"1954","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118161_b0160","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/reactions4030029","article-title":"Recent advances in the Synthesis of Pyrazole Derivatives: a Review","volume":"4","author":"Ameziane El Hassani","year":"2023","journal-title":"Reactions"},{"issue":"8","key":"10.1016\/j.bcp.2026.118161_b0165","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1021\/ol2004947","article-title":"Rapid One-Pot, Four-step Synthesis of Highly Fluorescent 1,3,4,5-Tetrasubstituted Pyrazoles","volume":"13","author":"Willy","year":"2011","journal-title":"Org. Lett."},{"key":"10.1016\/j.bcp.2026.118161_b0170","first-page":"10","article-title":"Application of Synthetic Low Molecular Weight Heterocyclic Compounds Derivatives of Pyrimidine, Pyrazole and Oxazole in Agricultural Biotechnology as a New Plant Growth Regulating Substances","author":"Tsygankova","year":"2017","journal-title":"Int. J. Med. Biotechnol. Genet."},{"key":"10.1016\/j.bcp.2026.118161_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117081","article-title":"Antibacterial and Antifungal Pyrazoles based on Different Construction strategies","volume":"282","author":"Rehman","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14233\/ajchem.2019.21455","article-title":"Development of 5-(Aryl)-3-Phenyl-1H-pyrazole Derivatives as Potent Antimicrobial Compounds","volume":"31","author":"Chrowdary","year":"2019","journal-title":"Asian J. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/14756366.2018.1530225","article-title":"Design, Synthesis, in Vitro Anticancer Evaluation, Kinase Inhibitory Effects, and Pharmacokinetic Profile of New 1,3,4-Triarylpyrazole Derivatives Possessing Terminal Sulfonamide Moiety","volume":"34","author":"Abdel-Maksoud","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2026.118161_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25061364","article-title":"Natural and Biomimetic Antitumor Pyrazoles, a Perspective","volume":"25","author":"Santos","year":"2020","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.bcp.2026.118161_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25245886","article-title":"Styrylpyrazoles: Properties, Synthesis and Transformations","volume":"25","author":"Gomes","year":"2020","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.bcp.2026.118161_b0200","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1039\/C9NJ01021A","article-title":"Novel Styrylpyrazole-Glucosides and their Dioxolo-Bridged Doppelgangers: Synthesis and Cytotoxicity","volume":"43","author":"Carreira","year":"2019","journal-title":"New J. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0205","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ijbiomac.2021.04.061","article-title":"Pyrazoles as Novel Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: an in Vitro and in Silico Study","volume":"181","author":"Rocha","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118161_b0210","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00706-007-0676-4","article-title":"Synthesis and Pharmacological Evaluation of Chlorinated N-Alkyl-3- and -5-(2-Hydroxyphenyl)Pyrazoles as CB1 Cannabinoid Ligands","volume":"138","author":"Silva","year":"2007","journal-title":"Monatsh. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2026.118161_b0215","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3390\/molecules29102298","article-title":"Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives","volume":"29","author":"Rapetti","year":"2024","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bcp.2026.118161_b0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4172\/2161-0444.1000359","article-title":"Pyrazole Derivatives with NCN Junction and their Biological activity: a Review","volume":"6","author":"Abrigach","year":"2016","journal-title":"Med. Chem. (los. Angeles)."},{"key":"10.1016\/j.bcp.2026.118161_b0225","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejmech.2014.03.033","article-title":"Synthesis, Structure-activity Relationships, and in Vitro Antibacterial and Antifungal activity evaluations of Novel Pyrazole Carboxylic and Dicarboxylic Acid Derivatives","volume":"78","author":"Mert","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2026.118161_b0230","first-page":"940","article-title":"Recent Advancement of Pyrazole Scaffold based Neuroprotective Agents: a Review","volume":"21","author":"Das","year":"2021","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"4","key":"10.1016\/j.bcp.2026.118161_b0235","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3831\/KPI.2018.21.026","article-title":"Neuroprotective Agents in the Intensive Care Unit","volume":"21","author":"Panahi","year":"2018","journal-title":"J. Pharmacopuncture"},{"key":"10.1016\/j.bcp.2026.118161_b0240","first-page":"1","article-title":"Pathogenesis of Alzheimer\u2019s Disease","volume":"24","author":"Rostagno","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118161_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2023.115215","article-title":"Potential Neuroprotective Agent in Neurodegenerative Diseases: from Chemistry to Medicine","volume":"165","author":"Jin","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3233\/JAD-131070","article-title":"Bindarit, Inhibitor of CCL2 Synthesis, Protects Neurons against Amyloid-\u03b2-Induced Toxicity","volume":"38","author":"Severini","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bcp.2026.118161_b0255","first-page":"1","article-title":"Inhibitory Effects of Edaravone in \u03b2-Amyloid-Induced Neurotoxicity in Rats","volume":"2014","author":"He","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"16","key":"10.1016\/j.bcp.2026.118161_b0260","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1073\/pnas.1422998112","article-title":"Edaravone Alleviates Alzheimer's Disease-type Pathologies and Cognitive Deficits","volume":"112","author":"Jiao","year":"2015","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.bcp.2026.118161_b0265","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10072-015-2314-y","article-title":"Edaravone Injection Ameliorates Cognitive Deficits in Rat Model of Alzheimer\u2019s Disease","volume":"36","author":"Yang","year":"2015","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118161_b0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12017-011-8155-9","article-title":"Oxidative stress and \u03b2-Amyloid Protein in Alzheimer's Disease","volume":"13","author":"Cai","year":"2011","journal-title":"Neuromolecular Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0275","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/09298673113209990181","article-title":"4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases","volume":"21","author":"Shoeb","year":"2024","journal-title":"Cur. Med. Chem."},{"issue":"253\u2013261","key":"10.1016\/j.bcp.2026.118161_b0280","first-page":"0891","article-title":"Role of 4-Hydroxy-2-nonenal (HNE) in the Pathogenesis of Alzheimer Disease and other selected Age-Related Neurodegenerative Disorders","volume":"111","author":"Di Domenico","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","article-title":"Four-hydroxynonenal, a product of Lipid Peroxidation, is increased in the Brain in Alzheimer's Disease","volume":"19","author":"Markesbery","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2026.118161_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox11020195","article-title":"Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection","volume":"11","author":"Cha","year":"2022","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.bcp.2026.118161_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen Synthase Kinase-3 Signaling in Alzheimer\u2019s Disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0300","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12035-025-05414-2","article-title":"Edaravone Protected from D-Galactose-Induced Cell Senescence via Reduction of DNA damage and Downregulation of p53, p21 and p16 Genes in PC12 Cells","volume":"63","author":"Malekinejad","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118161_b0305","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.bmcl.2017.01.050","article-title":"DL-3-n-Butylphthalide-Edaravone Hybrids as Novel dual Inhibitors of Amyloid-\u03b2 Aggregation and Monoamine Oxidases with High Antioxidant Potency for Alzheimer\u2019s Therapy","volume":"27","author":"Qiang","year":"2017","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bcp.2026.118161_b0310","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.3390\/molecules26123724","article-title":"Role of Monoamine Oxidase activity in Alzheimer\u2019s Disease: an Insight into the Therapeutic potential of Inhibitors","volume":"26","author":"Behl","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bcp.2026.118161_b0315","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/ijms26083647","article-title":"Improved Synthesis of Effective 3-(Indolin-6-yl)-4-(N-pyrazole-sulfonamide)-1H-pyrrolo[2,3-b]pyridine-based Inhibitors of NADPH Oxidase 2","volume":"26","author":"Potapov","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2026.118161_b0320","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1021\/acs.jnatprod.5b00156","article-title":"3,5-Diarylpyrazole Derivatives Obtained by Ammonolysis of the Total Flavonoids from Chrysanthemum Indicum Extract Show potential for the Treatment of Alzheimer\u2019s Disease","volume":"78","author":"Wu","year":"2015","journal-title":"J. Nat. Prod."},{"issue":"4","key":"10.1016\/j.bcp.2026.118161_b0325","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/ml300058m","article-title":"The \u03b2-Amyloid Hypothesis in Alzheimer's Disease: Seeing is Believing","volume":"3","author":"Kung","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bcp.2026.118161_b0330","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/cn300073s","article-title":"Role of aromatic side chains in amyloid \u03b2-protein aggregation","volume":"3","author":"Cukalevski","year":"2012","journal-title":"ACS Chem. Nerosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-023-00277-3","article-title":"Neuroinflammation in Alzheimer\u2019s Disease: Microglial Signature and their Relevance to Disease","volume":"43","author":"Sobue","year":"2023","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.bcp.2026.118161_b0340","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of Neuroinflammation in Neurodegeneration Development","volume":"8","author":"Zhang","year":"2023","journal-title":"Sig Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.bcp.2026.118161_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells8070655","article-title":"Synthesis and Evaluation of Novel Pyrazole Ethandiamide Compounds as Inhibitors of Human THP-1 Monocytic Cell Neurotoxicity","volume":"8","author":"McKenzie","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bcp.2026.118161_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26051202","article-title":"Pyrazole Scaffold Synthesis, Functionalization, and applications in Alzheimer\u2019s Disease and Parkinson\u2019s Disease Treatment (2011-2020)","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bcp.2026.118161_b0355","first-page":"4","article-title":"History and Progress of Hypotheses and Clinical Trials for Alzheimer\u2019s Disease","volume":"29","author":"Liu","year":"2019","journal-title":"Sig Transduct Target Ther."},{"key":"10.1016\/j.bcp.2026.118161_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111598","article-title":"Discovery of \u03b4-Sultone-Fused Pyrazoles for Treating Alzheimer\u2019s Disease: Design, Synthesis, Biological Evaluation and SAR Studies","volume":"181","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0365","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s Disease: Targeting the Cholinergic System","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bcp.2026.118161_b0370","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejmech.2014.10.049","article-title":"New Tetracyclic Tacrine Analogs Containing Pyrano[2,3-c]Pyrazole: Efficient Synthesis, Biological Assessment and Docking simulation Study","volume":"89","author":"Khoobi","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0375","unstructured":"Tacrine. DrugBank. https:\/\/go.drugbank.com\/drugs\/DB00382 (accessed 2024-06-04)."},{"issue":"16","key":"10.1016\/j.bcp.2026.118161_b0380","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cmdc.201700282","article-title":"Discovery of Potent dual Binding Site Acetylcholinesterase Inhibitors via Homo- and Heterodimerization of Coumarin-based Moieties","volume":"12","author":"Pisani","year":"2017","journal-title":"ChemMedChem"},{"issue":"21","key":"10.1016\/j.bcp.2026.118161_b0385","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1021\/acs.biochem.0c00274","article-title":"Humanin Blocks the Aggregation of Amyloid-\u03b2 Induced by Acetylcholinesterase, an effect Abolished in the Presence of IGFBP-3","volume":"59","author":"Price","year":"2020","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0390","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12668-016-0375-x","article-title":"Role of Acetylcholinesterase in \u03b2-Amyloid Aggregation Studied by Accelerated Molecular Dynamics","volume":"7","author":"Lushchekina","year":"2017","journal-title":"BioNanoScience"},{"issue":"11","key":"10.1016\/j.bcp.2026.118161_b0395","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/cmdc.201500334","article-title":"6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease","volume":"10","author":"Semenov","year":"2015","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.bcp.2026.118161_b0400","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4155\/fmc.15.41","article-title":"Pyranopyrazolotacrines as Nonneurotoxic, A\u03b2-Anti-Aggregating and Neuroprotective Agents for Alzheimer\u2019s Disease","volume":"7","author":"Chioua","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0405","doi-asserted-by":"crossref","unstructured":"Liu, Y.; Yan, B.: Winkler, D. A.: Fu, J.; Zhang, A. Competitive Inhibition Mechanism of Acetylcholinesterase without Catalytic Active Site Interaction: Study on Functionalized C60 Nanoparticles via in Vitro and in Silico Assays. ACS Applied Materials & Interfaces.2017,9(22), 18626-18638. doi: 10.1021\/acsami.7b05459.","DOI":"10.1021\/acsami.7b05459"},{"key":"10.1016\/j.bcp.2026.118161_b0410","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2017.07.072","article-title":"New Racemic Annulated Pyrazolo[1,2-b]Phthalazines as Tacrine-like AChE Inhibitors with potential use in Alzheimer\u2019s Disease","volume":"139","author":"Jalili-Baleh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0415","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1080\/14756366.2020.1801673","article-title":"Design, Synthesis and Biological Evaluation of Edaravone Derivatives Bearing the N-Benzyl Pyridinium Moiety as Multifunctional Anti-Alzheimer\u2019s Agents","volume":"35","author":"Zondagh","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118161_b0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2002-4309","article-title":"Amyloid Beta-Peptide and Amyloid Pathology are Central to the Oxidative stress and Inflammatory Cascades under which Alzheimer's Disease Brain Exists","volume":"4","author":"Butterfield","year":"2002","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bcp.2026.118161_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106869","article-title":"Edaravone N-Benzyl Pyridinium Derivatives: BACE-1 Inhibition, Kinetics and In Silico Binding Pose Determination","volume":"201","author":"Zondagh","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2026.118161_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2021.104792","article-title":"Design and Synthesis of Novel Coumarin Derivatives as potential Acetylcholinesterase Inhibitors for Alzheimer\u2019s Disease","volume":"110","author":"Amin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0435","doi-asserted-by":"crossref","unstructured":"R Manikandan, M.; K Devi, D.; D Rajalingam, R. Synthesis and Evaluation of 2, 5-substituted Pyrazolone for Neuroprotective Potential in SH-SY5Y Human Neuroblastoma Cells. Indian J. Pharm. Educ. Res, 2025,59 (1), 323\u2013332. doi: 10.5530\/ijper.20256349.","DOI":"10.5530\/ijper.20256349"},{"key":"10.1016\/j.bcp.2026.118161_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108052","article-title":"Design, Synthesis and Biological Evaluation of Novel Pyrazolinone Derivatives as Multifunctional Ligands for the Treatment of Alzheimer's Disease","volume":"154","author":"Wang","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0445","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jpp\/rgae075","article-title":"Pyrazolone-Nicotinic Acid Derivative (4Z)-4-(2-hydroxybenzylidine)-5-methyl-2-(pyridine-3-ylcarbonyl)-2,4-dihydro-3H-pyrazole-3-one (IIc) as Multitarget Inhibitor of Neurodegeneration and Behavioural Impairment in Dementia","volume":"77","author":"Kanwal","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118161_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2025.101804","article-title":"Design, Synthesis and Biological Evaluation of Naphthalene-Pyrazoline Derivatives as Neuroprotective Agents for Alzheimer's Disease","volume":"102","author":"Sharma","year":"2025","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.bcp.2026.118161_b0455","first-page":"2772","article-title":"Targeting Alzheimer's Disease with Novel Dual-function 3,5-diaryl-4,5-dihydro-1H-pyrazole-1-carbothioamide Derivatives","volume":"12","author":"Katsogiannou","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bcp.2026.118161_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111809","article-title":"Genetic and Functional Dynamics of Butyrylcholinesterase in Alzheimer's Disease: from Mechanisms to Clinical Relevance","volume":"423","author":"Pre\u0161ern","year":"2026","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.118161_b0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of Acetylcholinesterase Inhibitors in Alzheimer\u2019s Disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.118161_b0470","first-page":"1","article-title":"Natural Phenol Carbamates: Selective BuChE\/FAAH dual Inhibitors Show Neuroprotection in an Alzheimer\u2019s Disease Mouse Model","volume":"281","author":"Rong","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2020.112273","article-title":"The Structure-based Optimization of \u03b4-Sultone-Fused Pyrazoles as Selective BuChE Inhibitors","volume":"201","author":"Zhang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0480","doi-asserted-by":"crossref","unstructured":"Sunil, K.; Amritha, M.; Jayalakshmi, J.; Mohamed A., A; Wael A, M.; Sultan, A.; Mohammed M., G.; Leena K., P; Subin, Z.; Aneesh, T. P.; Bijo, M. Exploiting Butyrylcholinesterase Inhibitors Through a Combined 3-D Pharmacophore Modeling, QSAR, Molecular Docking, and Molecular Dynamics Investigation. RSC Adv., 2023, 13 (14), 9513\u20139529. doi: 10.1039\/d3ra00526g.","DOI":"10.1039\/D3RA00526G"},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0485","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/14756366.2022.2103553","article-title":"Fluorosulfate-Containing Pyrazole Heterocycles as Selective BuChE Inhibitors: Structure-activity Relationship and Biological Evaluation for the Treatment of Alzheimer\u2019s Disease","volume":"37","author":"Li","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108901","article-title":"DHEA-Carbamate Derivatives as dual Cholinesterase Inhibitors: Integration of Enzymatic and Biomolecular Interactions in Alzheimer's Disease","volume":"164","author":"Nar","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2026.118161_b0495","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.neurobiolaging.2014.03.023","article-title":"PDE9A Inhibition Rescues Amyloid Beta-Induced Deficits in Synaptic Plasticity and Cognition","volume":"35","author":"Kroker","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2026.118161_b0500","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1019187","article-title":"Inhibition of Phosphodiesterase: a Novel Therapeutic Target for the Treatment of Mild Cognitive Impairment and Alzheimer's Disease","volume":"14","author":"Sheng","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.bcp.2026.118161_b0505","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/acschemneuro.7b00268","article-title":"Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer\u2019s Disease","volume":"8","author":"Yu","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"14","key":"10.1016\/j.bcp.2026.118161_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bmcl.2020.127254","article-title":"Design, Synthesis and Evaluation of Pyrazolopyrimidinone Derivatives as Novel PDE9A Inhibitors for Treatment of Alzheimer\u2019s Disease","volume":"30","author":"Zhang","year":"2020","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bcp.2026.118161_b0515","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1124\/mol.105.017608","article-title":"Characterization of the first Potent and Selective PDE9 Inhibitor using a cGMP Reporter Cell Line","volume":"68","author":"Wunder","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118161_b0520","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainres.2016.04.011","article-title":"Protective Effects of BAY 73-6691, a Selective Inhibitor of Phosphodiesterase 9, on Amyloid-\u03b2 Peptides-Induced Oxidative stress in in-Vivo and in-Vitro Models of Alzheimer\u2019s Disease","volume":"1642","author":"Li","year":"2016","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.118161_b0525","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/1871527323666230811093126","article-title":"Phosphodiesterase 2 and its Isoform a as Therapeutic Targets in the Central nervous System Disorders","volume":"23","author":"Metkar","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bcp.2026.118161_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118302","article-title":"Discovery of Novel 2,4,5,6-tetrahydro-7H-pyrazolo[3,4-c]pyridine-7-one Derivatives as PDE2 Inhibitors with Alzheimer's Disease Therapeutic potential","volume":"302","author":"Yang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.118161_b0535","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/biom13030549","article-title":"The Role of the Transcription factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities","volume":"13","author":"De Plano","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bcp.2026.118161_b0540","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.neurot.2025.e00586","article-title":"Nrf2\/Bach1 Signaling Axis: a Promising Multifaceted Therapeutic Strategy for Alzheimer's Disease","volume":"22","author":"Soni","year":"2025","journal-title":"Neurotherapeutics"},{"issue":"17","key":"10.1016\/j.bcp.2026.118161_b0545","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1021\/acschemneuro.0c00363","article-title":"Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3\u03b2 Inhibitor\/Nrf2 Inducer for the Treatment of Parkinson\u2019s Disease","volume":"11","author":"Di Martino","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bcp.2026.118161_b0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep45701","article-title":"Discovery of the first dual GSK3\u03b2 Inhibitor\/Nrf2 Inducer. a New Multitarget Therapeutic Strategy for Alzheimer\u2019s Disease","volume":"7","author":"Gameiro","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0555","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/14756366.2018.1530223","article-title":"Computer-aided Molecular Design of Pyrazolotriazines Targeting Glycogen Synthase Kinase 3","volume":"34","author":"Sci\u00fa","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106663","article-title":"Synthesis and Biological Evaluation of Thieno[3,2-c]Pyrazol-3-Amine Derivatives as Potent Glycogen Synthase Kinase 3\u03b2 Inhibitors for Alzheimer\u2019s Disease","author":"Yan","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117799","article-title":"Exploiting Acylaminopyrazole Scaffold for Polypharmacology Approach in Alzheimer's Disease","volume":"295","author":"Orioli","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2026.118161_b0570","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2174\/1381612043384772","article-title":"Imaging Beta-Amyloid Plaques and Neurofibrillary Tangles in the Aging Human Brain","volume":"10","author":"Mathis","year":"2024","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2026.118161_b0575","doi-asserted-by":"crossref","unstructured":"Ok Yoon, S.; Ju Park, D.; Cheon Ryu, J.; Gulcin Ozer, H.; Tep, C.; Jae Shin, Y.; Hee Lim, T.; Pastorino, L.; Kunwar, A.J.; Walton, J.C.; Nagahara, A.H.; Ping Lu, K.; Nelson, R.J.; Tuszynski, M.H.; Huang,K. JNK3 Perpetuates Metabolic Stress Induced by A\u03b2 Peptides, Neuron, 2012, 75 (5), 824-837; doi: 10.1016\/j.neuron.2012.06.024.","DOI":"10.1016\/j.neuron.2012.06.024"},{"issue":"44","key":"10.1016\/j.bcp.2026.118161_b0580","doi-asserted-by":"crossref","first-page":"42060","DOI":"10.1074\/jbc.M202241200","article-title":"Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3\u03b2 and JNK3 Induces Oligomeric Tau Fibrils in COS-7 Cells","volume":"277","author":"Sato","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0585","article-title":"Targeting JNK3 for Alzheimer's Disease: Design and Synthesis of Novel Inhibitors with Aryl Group Diversity Utilizing Wide Pocket","volume":"285","author":"Kim","year":"2025","journal-title":"Eur. Jour. Med. Chem."},{"issue":"22","key":"10.1016\/j.bcp.2026.118161_b0590","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","article-title":"Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as potential Therapeutics","volume":"61","author":"Jarhad","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0595","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11030-024-10856-2","article-title":"Discovery of a Novel DYRK1A Inhibitor with Neuroprotective activity by Virtual Screening and In Vitro Biological Evaluation","volume":"29","author":"Si","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bcp.2026.118161_b0600","doi-asserted-by":"crossref","first-page":"70025","DOI":"10.1002\/ardp.70025","article-title":"Pyrazolopyridine-Containing Compounds as Multitargeted Anti-Alzheimer Agents: Synthesis, Biological Evaluation, and In Silico Studies","volume":"358","author":"Waly","year":"2025","journal-title":"Arch. Pharm."},{"issue":"5","key":"10.1016\/j.bcp.2026.118161_b0605","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00281-022-00947-3","article-title":"The Immunology of Parkinson\u2019s Disease","volume":"44","author":"Zhu","year":"2022","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0610","first-page":"1","article-title":"Signaling Pathways in Parkinson\u2019s Disease: Molecular Mechanisms and Therapeutic Interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2026.118161_b0615","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/antiox9070597","article-title":"The Role of Oxidative stress in Parkinson\u2019s Disease","volume":"9","author":"Chang","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.bcp.2026.118161_b0620","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s Disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"issue":"4","key":"10.1016\/j.bcp.2026.118161_b0625","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The Role of Oxidative stress in Parkinson's Disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.bcp.2026.118161_b0630","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2360872","article-title":"Oxidative stress in Parkinson\u2019s Disease: potential Benefits of Antioxidant Supplementation","author":"Perc\u00e1rio","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2026.118161_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/236182","article-title":"CNB-001 a Novel Curcumin Derivative, Guards Dopamine Neurons in MPTP Model of Parkinson\u2019s Disease","volume":"2014","author":"Jayaraj","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2026.118161_b0640","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0197-0186(92)90256-Q","article-title":"The MPTP-Treated Mouse as a Model of Parkinsonism: how good is it?","volume":"20","author":"Heikkila","year":"1992","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0645","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1476-5381.1993.tb13584.x","article-title":"Selective MPP+ Uptake into Synaptic Dopamine Vesicles: possible Involvement in MPTP Neurotoxicity","volume":"109","author":"Del Zompo","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118161_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177782","article-title":"Teneligliptin, a DPP4 Inhibitor Protects Dopaminergic Neurons in PD Models via Inhibiting of Oxidative stress and Ferroptosis","volume":"1002","author":"Huang","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118161_b0655","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and Immune Dysfunction in Parkinson Disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2026.118161_b0660","doi-asserted-by":"crossref","unstructured":"Troncoso-Escudero, P.; Parra, A.; Nassif, M.; Vidal, R. L.Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease.Front. Neurol. 2018, 9, 860. doi: 10.3389\/fneur.2018.00860.","DOI":"10.3389\/fneur.2018.00860"},{"issue":"8","key":"10.1016\/j.bcp.2026.118161_b0665","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11910-022-01207-5","article-title":"Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop","volume":"22","author":"Arena","year":"2022","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.bcp.2026.118161_b0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2014.06.022","article-title":"CNB-001, a Novel Pyrazole Derivative Mitigates Motor Impairments Associated with Neurodegeneration via suppression of Neuroinflammatory and Apoptotic Response in Experimental Parkinson\u2019s Disease mice","volume":"220","author":"Jayaraj","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2026.118161_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118526","article-title":"Targeting KCNN4 Channels Modulates Microglial Activation and Apoptosis in a PD-relevant Inflammatory Model","volume":"191","author":"Hung","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.bcp.2026.118161_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-023-08769-8","article-title":"Amelioration of Astrocyte-Mediated Neuroinflammation by EI-16004 Confers Neuroprotection in an MPTP-induced Parkinson's Disease Model","volume":"26","author":"Kim","year":"2024","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.bcp.2026.118161_b0685","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2017.02.019","article-title":"Synthesis of New Heterocyclic Compounds based on Pyrazolopyridine Scaffold and Evaluation of their Neuroprotective potential in MPP+-Induced Neurodegeneration","volume":"129","author":"Jouha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0690","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/acs.jmedchem.2c01410","article-title":"Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease","volume":"66","author":"Shuai","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0695","first-page":"1","article-title":"The Nrf2\/ARE Pathway: a Promising Target to Counteract Mitochondrial Dysfunction in Parkinson\u2019s Disease","volume":"2011","author":"Tufekci","year":"2011","journal-title":"Parkinsons. Dis."},{"key":"10.1016\/j.bcp.2026.118161_b0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2020.113387","article-title":"A Novel Pyrazolo [3,4-d] Pyrimidine, KKC080106, Activates the Nrf2 Pathway and Protects Nigral Dopaminergic Neurons","volume":"332","author":"Lee","year":"2020","journal-title":"Exp. Neurol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118161_b0705","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1021\/acsomega.3c10351","article-title":"Identification of Novel Quinolone and Quinazoline Alkaloids as Phosphodiesterase 10A inhibitors for Parkinson's Disease through a Computational Approach","volume":"9","author":"Ahmad","year":"2024","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bcp.2026.118161_b0710","first-page":"1","article-title":"The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson\u2019s Disease Mouse Models","volume":"16","author":"Kim","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118161_b0715","doi-asserted-by":"crossref","first-page":"70321","DOI":"10.1111\/jnc.70321","article-title":"Phosphodiesterase Inhibition increases Striatal GDNF and Protects against Preclinical Parkinsonism","volume":"169","author":"d'Anglemont de Tassigny","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2026.118161_b0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2020.113140","article-title":"Evaluation of the Cellular Protection by Novel Spiropyrazole Compounds in Dopaminergic Cell Death","volume":"213","author":"Zaiter","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118161_b0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116198","article-title":"Pyrazolamide Derivatives Inhibit \u03b1-Synuclein Aggregation, Disaggregate Preformed Fibers, and Reduce Inclusion Formation in Neuron Cells","volume":"268","author":"Xing","year":"2024","journal-title":"Eur. J. Med. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:15:51Z","timestamp":1785071751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226004983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":145,"alternative-id":["S0006295226004983"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118161","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current progress in the use of pyrazole-containing compounds for neuroprotection as a strategy to counteract neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118161"}}